✦ LIBER ✦

High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease

✍ Scribed by Winfred C. Wang; Edward H. Kovnar; Ina L. Tonkin; Raymond K. Mulhern; James W. Langston; Sara W. Day; Michael J. Schell; Judith A. Wilimas

Book ID: 117163401
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 512 KB
Volume: 118
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(05)82150-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of recurrent stroke in children wit

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke

✍ Douglas J. Scothorn; Cynthia Price; Daniel Schwartz; Cindy Terrill; George R. Bu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Risk of recurrent stroke in patients wit

Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions

✍ Charles H. Pegelow; Robert J. Adams; Virgil McKie; Miguel Abboud; Brian Berman; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Risk of recurrent stroke in children wit

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke: D.J. Scothorn, C Price, D. Schwartz, et al. J Peds 140:348–54, 2002

✍ Sunny Dzik 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 123 KB

FREQUENCY OF RECURRENCE AFTER DISCONTINU

FREQUENCY OF RECURRENCE AFTER DISCONTINUANCE OF ANTICONVULSANT THERAPY IN PATIENTS WITH EPILEPTIC SEIZURES. A NEW FOLLOW-UP AFTER FIVE YEARS

✍ Palle Juul-Jensen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Risk of recurrent stroke in patients wit

Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions: Pegelow CH, Adams RJ, McKie V, et al. J Pediatr 126:896–899, 1995

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 110 KB

High incidence of disease recurrence in

High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib

✍ Antonio M. P. Omuro; Mark G. Kris; Vincent A. Miller; Enrico Franceschi; Neelam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB